- Ironwood Pharmaceuticals (NASDAQ:IRWD) Q4 results: Revenues: $94.2M (+7.7%); Operating Income: $22.8M; Net Income: $12.1M; EPS: $0.08; Non-GAAP Loss Per Share: ($0.14) (-16.7%); Quick Assets: $221.4M (-27.5%).
- 2018 Guidance: R&D Expenses: $160M - 180M; SG&A Expenses: $230M - 250M; Net interest expense: less than $40M.
Ironwood Pharma Q4 revenues up 8%; updates guidance
Recommended For You
More Trending News
About IRWD Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
IRWD | - | - |
Ironwood Pharmaceuticals, Inc. |